The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Neuroprotection is defined as an involvement able to affect the etiology or the pathogenesis underlying neurodegenerative diseases.
The global Neuroprotection market size is expected to reach US$ 32780 million by 2029, growing at a CAGR of 4.5% from 2023 to 2029. The market is mainly driven by the significant applications of Neuroprotection in various end use industries.
The expanding demands from the Prevention and Treatment, are propelling Neuroprotection market. Free Anti-Inflammatory Agents, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Radical Trapping Agents (Antioxidants) segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Neuroprotection market, driven by demand from China, the second largest economy with some signs of stabilising, the Neuroprotection market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Neuroprotection, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Neuroprotection market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Neuroprotection market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Neuroprotection sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Neuroprotection covered in this report include F. Hoffmann-La Roche, Eli Lilly and Company, Daiichi Sankyo Company, Allergan, Novartis, AstraZeneca, Dr. Reddy's Laboratories, Astrocyte Pharmaceuticals and Teva Pharmaceutical Industries, etc.
The global Neuroprotection market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
- F. Hoffmann-La Roche
- Eli Lilly and Company
- Daiichi Sankyo Company
- Allergan
- Novartis
- AstraZeneca
- Dr. Reddy's Laboratories
- Astrocyte Pharmaceuticals
- Teva Pharmaceutical Industries
- Biogen
Global Neuroprotection market, by region:
- North America (U.S., Canada, Mexico)
- Europe (Germany, France, UK, Italy, etc.)
- Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
- South America (Brazil, etc.)
- Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Neuroprotection market, Segment by Type:
- Free Anti-Inflammatory Agents
- Radical Trapping Agents (Antioxidants)
- Apoptosis Inhibitors
- Glutamate Antagonists (Anti-Excitotoxic Agents)
- Neurotrophic Factors (NTFs)
- Stimulants
- Metal Ion Chelators
- Others
Global Neuroprotection market, by Application
- Prevention
- Treatment
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Neuroprotection companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index
1 Market Overview of Neuroprotection
1.1 Neuroprotection Market Overview
1.1.1 Neuroprotection Product Scope
1.1.2 Neuroprotection Market Status and Outlook
1.2 Global Neuroprotection Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Neuroprotection Market Size by Region (2018-2029)
1.4 Global Neuroprotection Historic Market Size by Region (2018-2023)
1.5 Global Neuroprotection Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Neuroprotection Market Size (2018-2029)
1.6.1 North America Neuroprotection Market Size (2018-2029)
1.6.2 Europe Neuroprotection Market Size (2018-2029)
1.6.3 Asia-Pacific Neuroprotection Market Size (2018-2029)
1.6.4 Latin America Neuroprotection Market Size (2018-2029)
1.6.5 Middle East & Africa Neuroprotection Market Size (2018-2029)
2 Neuroprotection Market by Type
2.1 Introduction
2.1.1 Free Anti-Inflammatory Agents
2.1.2 Radical Trapping Agents (Antioxidants)
2.1.3 Apoptosis Inhibitors
2.1.4 Glutamate Antagonists (Anti-Excitotoxic Agents)
2.1.5 Neurotrophic Factors (NTFs)
2.1.6 Stimulants
2.1.7 Metal Ion Chelators
2.1.8 Others
2.2 Global Neuroprotection Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Neuroprotection Historic Market Size by Type (2018-2023)
2.2.2 Global Neuroprotection Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Neuroprotection Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Neuroprotection Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Neuroprotection Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Neuroprotection Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Neuroprotection Revenue Breakdown by Type (2018-2029)
3 Neuroprotection Market Overview by Application
3.1 Introduction
3.1.1 Prevention
3.1.2 Treatment
3.2 Global Neuroprotection Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Neuroprotection Historic Market Size by Application (2018-2023)
3.2.2 Global Neuroprotection Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Neuroprotection Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Neuroprotection Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Neuroprotection Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Neuroprotection Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Neuroprotection Revenue Breakdown by Application (2018-2029)
4 Neuroprotection Competition Analysis by Players
4.1 Global Neuroprotection Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Neuroprotection as of 2022)
4.3 Date of Key Players Enter into Neuroprotection Market
4.4 Global Top Players Neuroprotection Headquarters and Area Served
4.5 Key Players Neuroprotection Product Solution and Service
4.6 Competitive Status
4.6.1 Neuroprotection Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 F. Hoffmann-La Roche
5.1.1 F. Hoffmann-La Roche Profile
5.1.2 F. Hoffmann-La Roche Main Business
5.1.3 F. Hoffmann-La Roche Neuroprotection Products, Services and Solutions
5.1.4 F. Hoffmann-La Roche Neuroprotection Revenue (US$ Million) & (2018-2023)
5.1.5 F. Hoffmann-La Roche Recent Developments
5.2 Eli Lilly and Company
5.2.1 Eli Lilly and Company Profile
5.2.2 Eli Lilly and Company Main Business
5.2.3 Eli Lilly and Company Neuroprotection Products, Services and Solutions
5.2.4 Eli Lilly and Company Neuroprotection Revenue (US$ Million) & (2018-2023)
5.2.5 Eli Lilly and Company Recent Developments
5.3 Daiichi Sankyo Company
5.3.1 Daiichi Sankyo Company Profile
5.3.2 Daiichi Sankyo Company Main Business
5.3.3 Daiichi Sankyo Company Neuroprotection Products, Services and Solutions
5.3.4 Daiichi Sankyo Company Neuroprotection Revenue (US$ Million) & (2018-2023)
5.3.5 Allergan Recent Developments
5.4 Allergan
5.4.1 Allergan Profile
5.4.2 Allergan Main Business
5.4.3 Allergan Neuroprotection Products, Services and Solutions
5.4.4 Allergan Neuroprotection Revenue (US$ Million) & (2018-2023)
5.4.5 Allergan Recent Developments
5.5 Novartis
5.5.1 Novartis Profile
5.5.2 Novartis Main Business
5.5.3 Novartis Neuroprotection Products, Services and Solutions
5.5.4 Novartis Neuroprotection Revenue (US$ Million) & (2018-2023)
5.5.5 Novartis Recent Developments
5.6 AstraZeneca
5.6.1 AstraZeneca Profile
5.6.2 AstraZeneca Main Business
5.6.3 AstraZeneca Neuroprotection Products, Services and Solutions
5.6.4 AstraZeneca Neuroprotection Revenue (US$ Million) & (2018-2023)
5.6.5 AstraZeneca Recent Developments
5.7 Dr. Reddy's Laboratories
5.7.1 Dr. Reddy's Laboratories Profile
5.7.2 Dr. Reddy's Laboratories Main Business
5.7.3 Dr. Reddy's Laboratories Neuroprotection Products, Services and Solutions
5.7.4 Dr. Reddy's Laboratories Neuroprotection Revenue (US$ Million) & (2018-2023)
5.7.5 Dr. Reddy's Laboratories Recent Developments
5.8 Astrocyte Pharmaceuticals
5.8.1 Astrocyte Pharmaceuticals Profile
5.8.2 Astrocyte Pharmaceuticals Main Business
5.8.3 Astrocyte Pharmaceuticals Neuroprotection Products, Services and Solutions
5.8.4 Astrocyte Pharmaceuticals Neuroprotection Revenue (US$ Million) & (2018-2023)
5.8.5 Astrocyte Pharmaceuticals Recent Developments
5.9 Teva Pharmaceutical Industries
5.9.1 Teva Pharmaceutical Industries Profile
5.9.2 Teva Pharmaceutical Industries Main Business
5.9.3 Teva Pharmaceutical Industries Neuroprotection Products, Services and Solutions
5.9.4 Teva Pharmaceutical Industries Neuroprotection Revenue (US$ Million) & (2018-2023)
5.9.5 Teva Pharmaceutical Industries Recent Developments
5.10 Biogen
5.10.1 Biogen Profile
5.10.2 Biogen Main Business
5.10.3 Biogen Neuroprotection Products, Services and Solutions
5.10.4 Biogen Neuroprotection Revenue (US$ Million) & (2018-2023)
5.10.5 Biogen Recent Developments
6 North America
6.1 North America Neuroprotection Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Neuroprotection Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Neuroprotection Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Neuroprotection Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Neuroprotection Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Neuroprotection Market Dynamics
11.1 Neuroprotection Industry Trends
11.2 Neuroprotection Market Drivers
11.3 Neuroprotection Market Challenges
11.4 Neuroprotection Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
